A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study evaluated the long-term safety and efficacy of afegostat tartrate in participants
with Gaucher disease who were enrolled in a previous Phase 2 study of afegostat tartrate.